Keyphrases
Type I Diabetes
100%
Type 1 Diabetes Mellitus (T1DM)
100%
Celiac Disease
67%
Phase I Trial
33%
N-3 Polyunsaturated Fatty Acids
33%
Vitamin D
33%
Tolerability
33%
Enterovirus Infection
33%
Microbial Infection
33%
Coxsackie B Virus
33%
Immunogenicity
33%
Asthma
33%
Serum 25-hydroxyvitamin D
33%
Infections in children
33%
Birth Cohort Study
33%
Exposome
33%
Allergy
33%
Project Approach
33%
Fatty Acids
33%
Randomized Placebo-controlled Trial
33%
Placebo
33%
Multivalent Vaccine
33%
25-hydroxyvitamin D (25OHD)
33%
Immune-mediated Diseases
33%
Vaccine Target
33%
Inflammation Risk
33%
Islet Autoimmunity
33%
Gut Inflammation
33%
Inflammation Markers
33%
Nested Case-control Study
33%
Pneumococcal Vaccine
33%
Soil Microbiome
33%
Skin Exposure
33%
Cellular Immunity
33%
Confidence Interval
29%
HBD-2
29%
Intervention Group
25%
Vaccine Response
25%
Multivalent
22%
Titre
22%
IgG Antibody
22%
Injection Site
22%
Docosahexaenoic Acid
22%
High Dose
22%
Immune Response
22%
Rotavirus
22%
Decreased Risk
22%
At Birth
22%
Virus
22%
Adenovirus Infection
20%
Immunology and Microbiology
Coeliac Disease
67%
Enterovirus
50%
Immunity
42%
Immune Response
33%
Pneumococcal Vaccine
33%
Asthma
33%
Soil Microflora
33%
Rotavirus
33%
Adoptive Immunity
33%
Adenoviridae
20%
Respiratory Syncytial Virus Infection
16%
Serum (Blood)
16%
Viral Disease
16%
Fatty Acid Blood Level
16%
Enterovirus B
16%
Immunoglobulin G
16%
Influenzavirus A
16%
Neutralization
16%
Infancy
16%
Seropositivity
16%
Microorganism
16%
Enzyme Immunoassay
16%
Serotype
16%
Immunology
16%
Immunoglobulin G Antibody
16%
Peripheral Blood Mononuclear Cell
16%
Antibody Response
8%
Cytokine
8%
Immune System
8%
Blood Level
8%
Blood Plasma
8%
Cytokine Production
8%
Tissue Transglutaminase
6%
Virus Antibody
6%
Autoantibodies
6%
Seroconversion
6%
HLA-DQ
6%
Medicine and Dentistry
Insulin Dependent Diabetes Mellitus
74%
Disease
39%
Coeliac Disease
33%
Immunogenicity
33%
Asthma
33%
Placebo
33%
Phase I Trials
33%
Enterovirus B
33%
Gut
33%
Case-Control Study
33%
Autoimmunity
33%
Immunity
33%
HBD
20%
Serotype
16%
Infection
16%
Adverse Event
16%
Drug Megadose
11%
Low Drug Dose
11%
Disease Burden
7%
Calgranulin
6%
Odds Ratio
6%
Intramuscular Injection
5%
Antibody Response
5%
Neutralizing Antibody
5%
Formaldehyde
5%
Chronic Disease
5%
Diabetes
5%
Common Cold
5%
Headache
5%
Injection Site Discomfort
5%
Injection Site Pruritus
5%
Injection Site Pain
5%
Inactivated Vaccine
5%
Informed Consent
5%
Enzyme Linked Immunosorbent Assay
5%
